Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.

作者: Eve Wittenberg , Jeremy W. Bray , Brandon Aden , Achamyeleh Gebremariam , Bohdan Nosyk

DOI: 10.1111/ADD.13219

关键词:

摘要: AIMS To understand how the general public views quality of life effects opioid misuse and use disorder on an individual his/her spouse, measured in terms used economic evaluations. DESIGN Cross-sectional internet survey a US population-representative respondent panel conducted December 2013-January 2014. SETTING United States. PARTICIPANTS A total 2054 randomly selected adults; 51.1% male (before weighting). MEASUREMENTS Mean (95% confidence interval) median health 'utility' for six treatment outcomes: active injection misuse; prescription methadone maintenance therapy at initiation when stabilized treatment; buprenorphine stabilized. Utility is numerical representation health-related evaluations to 'adjust' estimated survival include peoples' preferences states. Utilities are determined by surveying population estimate value they assign particular states scale where 0 = the being dead 1.0 = the perfect health. Spouse spillover utility assigned spouse who state. FINDINGS ranged from 0.574 [95% confidence interval (CI) = 0.538, 0.611] 0.766 CI = 0.738, 0.795), with other between. Female respondents higher than did males (P < 0.05); all not differ gender. spousal utilities were significantly lower 1.0 but mostly utility, similar between female respondents. CONCLUSIONS In opinion public, results worse misuse, therapy. Spouses negatively affected their partner's early treatment.

参考文章(39)
Lisa A. Prosser, Scott D. Grosse, Eve Wittenberg, Health utility elicitation: is there still a role for direct methods? PharmacoEconomics. ,vol. 30, pp. 83- 86 ,(2012) , 10.2165/11597720-000000000-00000
Eve Wittenberg, Lisa A. Prosser, Ordering errors, objections and invariance in utility survey responses: a framework for understanding who, why and what to do. Applied Health Economics and Health Policy. ,vol. 9, pp. 225- 241 ,(2011) , 10.2165/11590480-000000000-00000
Roman Jaeschke, Joel Singer, Gordon H. Guyatt, Measurement of health status: Ascertaining the minimal clinically important difference Controlled Clinical Trials. ,vol. 10, pp. 407- 415 ,(1989) , 10.1016/0197-2456(89)90005-6
Bohdan Nosyk, Huiyung Sun, Daphne P. Guh, Eugenia Oviedo-Joekes, David C. Marsh, Suzanne Brissette, Martin T. Schechter, Aslam H. Anis, The quality of eight health status measures were compared for chronic opioid dependence. Journal of Clinical Epidemiology. ,vol. 63, pp. 1132- 1144 ,(2010) , 10.1016/J.JCLINEPI.2009.12.003
Mary-Lynn Brecht, David Huang, Elizabeth Evans, Yih-Ing Hser, Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users. Drug and Alcohol Dependence. ,vol. 96, pp. 193- 201 ,(2008) , 10.1016/J.DRUGALCDEP.2008.01.021
Lisa A. Prosser, Kara Lamarand, Acham Gebremariam, Eve Wittenberg, Measuring Family HRQoL Spillover Effects Using Direct Health Utility Assessment Medical Decision Making. ,vol. 35, pp. 81- 93 ,(2015) , 10.1177/0272989X14541328
Eve Wittenberg, Lisa A. Prosser, Disutility of Illness for Caregivers and Families: A Systematic Review of the Literature PharmacoEconomics. ,vol. 31, pp. 489- 500 ,(2013) , 10.1007/S40273-013-0040-Y
Colleen L. Barry, Haiden A. Huskamp, Moving beyond Parity — Mental Health and Addiction Care under the ACA New England Journal of Medicine. ,vol. 365, pp. 973- 975 ,(2011) , 10.1056/NEJMP1108649
Donald A. Redelmeier, Gordon H. Guyatt, Roger S. Goldstein, Assessing the Minimal Important Difference in Symptoms: A Comparison of Two Techniques Journal of Clinical Epidemiology. ,vol. 49, pp. 1215- 1219 ,(1996) , 10.1016/S0895-4356(96)00206-5